Process information
| Key Data Set Information | |
| Location | XT-HEB-CN |
| Reference year | 2023 |
| Name |
|
| Use advice for data set | When using this data set for environmental impact assessments or life cycle analyses, users should carefully consider each stage described – seed culture, fermentation, refining, and drying. It is paramount to account for the energy and material inputs at each stage, as well as waste and wastewater outputs, especially during the refining and drying processes where resource consumption and effluent generation may be substantial. Additionally, users should pay attention to the public release date of the environmental impact report for the latest data. |
| Technical purpose of product or process | The production of Acarbose, an active pharmaceutical ingredient (API), is conducted through a biological fermentation process. This API is primarily used in the pharmaceutical industry for the manufacture of diabetes medication, aiding in the management of blood sugar levels for patients with Type 2 diabetes. |
| Classification |
Class name
:
Hierarchy level
|
| General comment on data set | The information comes from the environmental assessment report of the enterprise and represents the actual production situation of the enterprise |
| Copyright | No |
| Owner of data set | |
| Quantitative reference | |
| Reference flow(s) | |
| Time representativeness | |
| Time representativeness description | Environmental impact assessment report publication date |
| Technological representativeness | |
| Technology description including background system | Acarbose was produced by biological fermentation, including seed culture, fermentation, refining and drying of finished products |
| Flow diagram(s) or picture(s) | |
Modelling and validation
Administrative information
Inputs and Outputs